Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Oxford BioMedica

This page shows the latest Oxford BioMedica news and features for those working in and with pharma, biotech and healthcare.

Oxford Biomedica gets £53m cash injection from Novo venture arm

Oxford Biomedica gets £53m cash injection from Novo venture arm

Cell and gene therapy specialist Oxford Biomedica has been given a £53.5m infusion of cash from Novo Holdings in exchange for a 10% stake in the company. ... John Dawson. “We are delighted that Novo Holdings has become a shareholder in Oxford Biomedica

Latest news

More from news
Approximately 3 fully matching, plus 36 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Pharma industry appointments Pharma industry appointments

    Prior to this, he was non-executive director and then chairman of Oxford BioMedica, a gene-based biopharmaceutical company.

  • Dr Simon Chandler joins Ora as a senior director Dr Simon Chandler joins Ora as a senior director

    Prior to joining Ora, Dr Chandler served as principal of Sci-pHecta Consulting from 2013 and has also held leadership roles at Bausch Lamb, Ista Pharmaceuticals, NightStaRx BioPharmaceuticals and Oxford BioMedica

  • ABPI names first project director for manufacturing ABPI names first project director for manufacturing

    James Christie joins from Oxford BioMedica. The Association of the British Pharmaceutical Industry (ABPI) has named James Christie as its first project director with responsibility for manufacturing. ... Prior to joining ABPI, Christie worked for Oxford

  • Paul Blake joins Oxford BioMedica Paul Blake joins Oxford BioMedica

    John Dawson, CEO of Oxford BioMedica, said: “His insight and guidance as a Non-Executive Board member have been invaluable and his extensive experience in the strategic clinical development of innovative ... therapies will be important to Oxford

  • BIA elects six new board members BIA elects six new board members

    The remaining new appointments are Stephen Taylor of Fujifilm Diosynth Biotechnologies; Donna Hackett, director of life sciences consultancy firm KDH BioManagement; and Tim Watts, chief financial officer of Oxford BioMedica.

More from appointments
Approximately 1 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Quick links

Infographics

Multimedia